Literature DB >> 12730493

Regulation of fetal growth by the somatotrophic axis.

Peter D Gluckman1, Catherine S Pinal.   

Abstract

Suboptimal fetal growth is associated with higher fetal mortality and with higher neonatal morbidity and mortality. It increases the likelihood of premature birth that in turn further compounds perinatal health risks. Moreover, an abnormal fetal environment, as reflected in an altered birth size phenotype, increases the propensity for disease in childhood and adulthood. Fetal growth represents the culmination of interaction between the fetal genome and the in utero environment determined by maternal-placental function. The role of endocrine and metabolic factors in mediating this interaction will be reviewed. There is also evidence that fetal growth, as measured in late gestation, is dependent not only on the maternal environment but on events that occurred during the periconceptual period. Thus, fetal growth not only reflects the immediate fetal environment but events surrounding conception and embryonic life.

Mesh:

Substances:

Year:  2003        PMID: 12730493     DOI: 10.1093/jn/133.5.1741S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  44 in total

Review 1.  Determinants of fetal growth.

Authors:  David A Sacks
Journal:  Curr Diab Rep       Date:  2004-08       Impact factor: 4.810

Review 2.  Growth hormone during development.

Authors:  Joy Osafo; Yuhong Wei; Gurvinder Kenth; Cynthia Gates Goodyer
Journal:  Rev Endocr Metab Disord       Date:  2005-08       Impact factor: 6.514

3.  Mechanical-tactile stimulation (MTS) intervention in a neonatal stress model improves long-term outcomes on bone.

Authors:  S Haley; S O'Grady; K Gulliver; B Bowman; R Baldassarre; S Miller; R H Lane; L J Moyer-Mileur
Journal:  J Musculoskelet Neuronal Interact       Date:  2011-09       Impact factor: 2.041

4.  H19 rs217727 genotype and IGF-1/intron -2 dinucleotide CT repeat polymorphism are independently associated with birth weight.

Authors:  A S Hewage; P Jayanthiny; K H Tennekoon; J M Kumarasiri; A P De S Wijesundere; E H Karunanayake
Journal:  Endocrine       Date:  2014-08-31       Impact factor: 3.633

5.  Early growth velocities and weight gain plasticity improve linear growth in Peruvian infants.

Authors:  Lora L Iannotti; Nelly Zavaleta; Clara Huasaquiche; Zulema Leon; Laura E Caulfield
Journal:  Matern Child Nutr       Date:  2012-10-01       Impact factor: 3.092

6.  Exposure of decidualized HIESC to low oxygen tension and leucine deprivation results in increased IGFBP-1 phosphorylation and reduced IGF-I bioactivity.

Authors:  Majida Abu Shehab; Kyle Biggar; Sahil Sagar Singal; Karen Nygard; Shawn Shun-Cheng Li; Thomas Jansson; Madhulika B Gupta
Journal:  Mol Cell Endocrinol       Date:  2017-04-21       Impact factor: 4.102

7.  Dwarfism and increased adiposity in the gh1 mutant zebrafish vizzini.

Authors:  Sarah K McMenamin; James E N Minchin; Tiffany N Gordon; John F Rawls; David M Parichy
Journal:  Endocrinology       Date:  2013-03-01       Impact factor: 4.736

8.  Increased IGFBP-1 phosphorylation in response to leucine deprivation is mediated by CK2 and PKC.

Authors:  Niyati Malkani; Kyle Biggar; Majida Abu Shehab; Shawn Shun-Cheng Li; Thomas Jansson; Madhulika B Gupta
Journal:  Mol Cell Endocrinol       Date:  2015-12-28       Impact factor: 4.102

9.  Individualized fetal growth assessment: critical evaluation of key concepts in the specification of third trimester size trajectories.

Authors:  Russell L Deter; Wesley Lee; Haleh Sangi-Haghpeykar; Adi L Tarca; Lami Yeo; Roberto Romero
Journal:  J Matern Fetal Neonatal Med       Date:  2013-09-12

10.  Periconceptional maternal folic acid use of 400 microg per day is related to increased methylation of the IGF2 gene in the very young child.

Authors:  Régine P Steegers-Theunissen; Sylvia A Obermann-Borst; Dennis Kremer; Jan Lindemans; Cissy Siebel; Eric A Steegers; P Eline Slagboom; Bastiaan T Heijmans
Journal:  PLoS One       Date:  2009-11-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.